OSAKA -- A Japanese research team is developing an immunotherapy to treat COVID-19 using embryonic stem cells.
The researchers at Kyoto University, led by Hiroshi Kawamoto, have developed a way to genetically engineer embryonic stem cells to produce killer T cells, a type of white blood cell that can search for and destroy infected cells in the body.
.JPG?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
